Calendar

Events that a source expects, grouped by the month, quarter or half-year the source names, with who expected each and when they said so.

Upcoming as of , the date this release was built (the newest input commit date), not today's date. An expected date is a statement by the source, not a result, and it can move. Dated events are on the timeline.

8,817 of these dates come from registry records: the start, primary completion or completion that a registry expects of a trial. A program assembled them, and a registry often leaves a date unchanged after it has passed. The calendar file lists the dates of written pages only.

Add to your calendar (calendar.ics)

The calendar file has one all-day event for each upcoming item. Where a source gives only a month, a quarter, a half-year or a year, the event sits on the first day of that period and its title says "expected sometime in" the period.

Upcoming

December 2026 407

  1. Primary completion Diabetic Foot Ulcer Research Study Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05762432

  2. Study completion Impact of Aerosol Box Use During Cardiopulmonary Arrest: A Multicenter Study Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05868239

  3. Primary completion Prophylactic Permanent Pacemaker in Patients With Right Bundle Branch Block Undergoing Transcatheter Aortic Valve Implantation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05889208

  4. Study completion The Man Van Project Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06357416

  5. Study completion IcoSApent ethyL to Slow Down Aortic VAlve Stenosis proGrEssion Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06466278

  6. Study completion PVP-Guided Decongestive Therapy in HF 2 Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06495892

  7. Primary completion Efficacy and Safety of Tenecteplase Bridging Mechanical Thrombectomy for Acute Large Vessel Occlusion Stroke Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06658197

  8. Primary completion Valvular Assessment of New Generation Aortic Replacement Devices Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06688448

  9. Study completion Left Septal Pacing or Left Bundle Branch Pacing to Avoid Left Ventricle Systolic Dysfunction Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06707662

  10. Primary completion Left Septal Pacing or Left Bundle Branch Pacing to Avoid Left Ventricle Systolic Dysfunction Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06707662

  11. Primary completion Effects of Nicorandil on Microvascular Dysfunction in Patients With STEMI Undergoing Primary PCI Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06787430

  12. Study start Application of TAVI at Experienced Interventional Cardiac Centers Without On-site Cardiac Surgery (ATLAS Study) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06818006

  13. Study completion Clinical Study on the Intervention of Xuesaitong Soft Capsules in Post-Intervention Patients with Acute Coronary Syndrome and Clinical Research Protocol Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06845254

  14. Study completion Microvascular Obstruction Diagnosis Using the CoFI™ System Assessment - II Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06909578

  15. Primary completion Microvascular Obstruction Diagnosis Using the CoFI™ System Assessment - II Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06909578

  16. Study completion Development and Validation of a Comprehensive Management Service Package for Older Adults With Multimorbidity Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07151430

  17. Study completion Bioimpedance Integration for Optimized Fluid Management in Decompensated Heart Failure Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07173426

  18. Study start Effects of Vibration-Assisted Physical Activity in Type-2 Diabetes Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07350473

  19. Study completion VASC-AF Study: Vascular Closure vs Manual Compression Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07414121

  20. Study completion AERO CAD Study Evaluating the Shockwave C2 Aero IVL System in Coronary Artery Disease Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07512206

  21. Study start A Phase II Clinical Study of LT3001 for Injection in the Treatment of Acute Ischemic Stroke Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07754825

  22. Study start Capital Offload-Shock Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07756801

  23. Study start Efficacy and Safety of Semaglutide Versus Placebo on Cardiometabolic Profile in Patients With Schizophrenia With Metabolic Syndrome Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07770282

  24. Study start IVUS-Guided Sirolimus-Coated Balloon Versus Sirolimus-Eluting Stent for De Novo Large Vessel Lesions in ACS Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07796412

  25. Study start Neuromodulation Combined With Dual FES Cycling and Cognitive Training After Stroke Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07807176

  26. Study start Combined Acupuncture-Based Therapy for Rehabilitation After Ischemic Stroke Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07846488

  27. Study start Ceasing Alpha-blockers Early After Resection of the Prostate (The CLEAR Trial) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07846579

  28. Study start The Impact of Using Nicorandil for the Prevention of Doxorubicin-Induced Cardiotoxicity Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07897409

  29. Study start Recombinant Human Prourokinase for Acute Ischemic Stroke in the Extended Window Selected by CT-Based Artificial Intelligence Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07901842

  30. Study start Early Mineralocorticoid Receptor Antagonist Therapy for Low-Renin Essential Hypertension Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07932145

  31. Study start Ramadan Nutrition Plan (RNP) Education for Glycaemic Control in Older Adults With Type 2 Diabetes in Yogyakarta Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07932210

  32. Study completion Edaravone Dexborneol for Blood-Brain Barrier Repair in Acute Anterior Circulation Stroke Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07933692

  33. Primary completion Edaravone Dexborneol for Blood-Brain Barrier Repair in Acute Anterior Circulation Stroke Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07933692

  34. Study start Single-Arm Trial of Carotid Stenting for Carotid Stenosis (Timing Trial) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07934563

  35. Study start Efficacy and Safety of High-Flow Nasal Cannula During Transcatheter Closure Procedures Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07937579

  36. Study start Artificial Intelligence-enabled Management of Atrial Fibrillation(ABLE-AF Trial) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07938281

  37. Study start Sotagliflozin Versus Empagliflozin Added to Metformin for Glycemic Control in Type 2 Diabetes Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07939750

  38. Study completion The Fenofibrate And Microvascular Events in Type 1 Diabetes Eye. Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01320345

  39. Study completion Effects of N-acetyl Cysteine During Primary Percutaneous Coronary Intervention Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01878344

  40. Study completion Effects of N-acetyl Cysteine During Percutaneous Coronary Intervention Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01878669

  41. Study completion Portico Re-sheathable Transcatheter Aortic Valve System US IDE Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02000115

  42. Study completion Efficacy of Three Dimensional Transesophageal Echocardiography for Percutaneous Device Closure in Atrial Septal Defect Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02097758

  43. Primary completion Efficacy of Three Dimensional Transesophageal Echocardiography for Percutaneous Device Closure in Atrial Septal Defect Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02097758

  44. Primary completion Quality Improvement and Practice Based Research in Neurology Using the EMR Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02670161

  45. Primary completion COMPASSION S3 - Evaluation of the SAPIEN 3 Transcatheter Heart Valve in Patients With Pulmonary Valve Dysfunction Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02744677

  46. Study completion NT-proBNP Selected Prevention of Cardiac Events in Diabetic Patients Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02817360

  47. Study completion Randomised Evaluation of Sodium Dialysate Levels on Vascular Events Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02823821

  48. Primary completion Randomised Evaluation of Sodium Dialysate Levels on Vascular Events Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02823821

  49. Study completion The Chocolate Touch Study Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02924857

  50. Primary completion Multicentre Study of MITRACLIP® Transcatheter Mitral Valve Repair in Patients With Severe Primary Mitral Regurgitation Eligible for High-risk Surgery Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03271762

  51. Study completion A Series of Pilot Studies to Evaluate the haemoDynamic and mEtabolic Effects oF apelIn aNd rElaxin Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03449251

  52. Primary completion A Series of Pilot Studies to Evaluate the haemoDynamic and mEtabolic Effects oF apelIn aNd rElaxin Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03449251

  53. Study completion Medtronic Terminate AF Study Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03546374

  54. Primary completion PROphylaxis for Venous ThromboEmbolism in Severe Traumatic Brain Injury (PROTEST) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03559114

  55. Primary completion Targeting Risk Interventions and Metformin for Atrial Fibrillation (TRIM-AF) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03603912

  56. Study completion Extension Study to Evaluate the Safety of Long-Term Use of Relacorilant in Patients With Cushing Syndrome Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03604198

  57. Primary completion Extension Study to Evaluate the Safety of Long-Term Use of Relacorilant in Patients With Cushing Syndrome Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03604198

  58. Study completion A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03683186

  59. Primary completion A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03683186

  60. Primary completion Outcome Research to Confirm the Anti-anginal Effect of T89 in Patients With Stable Angina Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03789552

  61. Study completion Ticagrelor With Low-dose Versus Regular Aspirin in Patients With Acute Coronary Syndrome (ACS) at High-Risk for Ischemia After Percutaneous Coronary Intervention Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04240834

  62. Primary completion The MITRAL II Pivotal Trial (Mitral Implantation of TRAnscatheter vaLves). Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04408430

  63. Study completion Sirolimus Coated Balloon Versus Standard Balloon for SFA and Popliteal Artery Disease Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04511234

  64. Primary completion SirolimUs CoaTed Balloon for The TrEatment of Below The Knee Arterial Disease Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04511247

  65. Study completion Examination of the Impact of CalmiGo's Stress Management Device on Vascular Heath and Cardiovascular Disease Risk. Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04521699

  66. Primary completion Examination of the Impact of CalmiGo's Stress Management Device on Vascular Heath and Cardiovascular Disease Risk. Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04521699

  67. Study completion Effect of Postoperative Prolonged Sedation With Dexmedetomidine After Successful Reperfusion With EVT on Long-term Prognosis in Patients With AIS (PPDET) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04916197

  68. Primary completion Effect of Postoperative Prolonged Sedation With Dexmedetomidine After Successful Reperfusion With EVT on Long-term Prognosis in Patients With AIS (PPDET) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04916197

  69. Study completion Treatment of Acute Ischemic Stroke (ReMEDy2 Trial) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05065216

  70. Primary completion Treatment of Acute Ischemic Stroke (ReMEDy2 Trial) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05065216

  71. Primary completion Cardiovascular Diseases and Diabetes Prevention Programme in Metabolic Syndrome (CDPP) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05105321

  72. Study completion Colchicine and Inflammation in Aortic Stenosis Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05162742

  73. Primary completion Colchicine and Inflammation in Aortic Stenosis Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05162742

  74. Study completion CAPITAL DOREMI 2: Inotrope Versus Placebo Therapy for Cardiogenic Shock Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05267886

  75. Primary completion CAPITAL DOREMI 2: Inotrope Versus Placebo Therapy for Cardiogenic Shock Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05267886

  76. Primary completion A Clinical Study of the Paradise™ Renal Denervation System in Patients With Hypertension (RADIANCE-HTN DUO) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05326230

  77. Study completion Evaluation of Nurse-led Integrated Care of Complex Patients Facilitated By Telemonitoring: The SMaRT Study Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05543720

  78. Primary completion Evaluation of Nurse-led Integrated Care of Complex Patients Facilitated By Telemonitoring: The SMaRT Study Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05543720

  79. Primary completion Intracranial Hemorrhage Risk of Intensive Statin in Acute Ischemic Stroke With Cerebral Microbleeds Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05589454

  80. Primary completion NOAC Therapy Guided by PARIS Risk Score and D-dimer in Patients With ACS After PCI Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05638867

  81. Study completion Air Pollution and Cardiovascular Disease in Qatar: an Interventional Study to Reduce Blood Pressure Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05903950

  82. Primary completion Air Pollution and Cardiovascular Disease in Qatar: an Interventional Study to Reduce Blood Pressure Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05903950

  83. Primary completion The THOR IDE Study Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05916950

  84. Study completion Effect of Butyphthalide on Cognitive Level Change After Cerebral Vascular Event-a Randomized Control Trial (Be-CLEVER) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05976152

  85. Primary completion Effect of Butyphthalide on Cognitive Level Change After Cerebral Vascular Event-a Randomized Control Trial (Be-CLEVER) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05976152

  86. Primary completion BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06059638

  87. Study completion Tongxinluo Capsule in the Treatment of Cerebral Small Vessel Disease-A Randomized, Double-blind, Placebo-controlled, Multicenter Clinical Study(TOPS-CSVD) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06061692

  88. Study completion Clinical Study on the Noninvasive Lung Fluid Monitoring System in Guiding the Treatment of Heart Failure Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06102031

  89. Study completion IDEAL Study: Blinded RCT for the Impact of AI Model for Cerebral Aneurysms Detection on Patients' Diagnosis and Outcomes Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06118840

  90. Study completion A Study to Evaluate the Efficacy and Safety of BR1019A and BR1019B Combination Therapy Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06220773

  91. Primary completion A Study to Evaluate the Efficacy and Safety of BR1019A and BR1019B Combination Therapy Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06220773

  92. Primary completion Smartphone Twelve-Lead ECG Utility In ST-Elevation Myocardial Infarction II Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06271577

  93. Study completion Open-label Extension Study of Seralutinib in Adult Subjects With PAH (PROSERA-EXT) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06274801

  94. Primary completion Open-label Extension Study of Seralutinib in Adult Subjects With PAH (PROSERA-EXT) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06274801

  95. Study completion Advapro Coronary Stent System in Coronary Artery Diseased Patients. Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06300268

  96. Study completion Tirofiban for Patients With intraCranial Artery Stenosis and High-risk Acute Non-disabling Cerebrovascular Events(CHANCE-4) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06319846

  97. Study completion Comparison of Individualized Sodium Management Versus Standard Treatment in Hemodialysis Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06341452

Overdue

The expected date has passed and no published record says the event happened. This does not mean it failed or was delayed: the atlas may not have checked the source since. Oldest first.

  1. Study completion Roux-en-Y Versus Billroth II Reconstruction After Subtotal Gastrectomy in Gastric Cancer Comorbid With Type II Diabetes Registry record

    Expected 2013-03; that period ended on 2013-03-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01528059

  2. Primary completion Diagnostic Performance of Noninvasive Fractional Flow Reserve From Computed Tomography Registry record

    Expected 2013-03; that period ended on 2013-03-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01747317

  3. Primary completion Novel Treatment for Coronary Artery Disease Registry record

    Expected 2013-04; that period ended on 2013-04-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01228214

  4. Study completion Comparison of Effect of cARvedilol Compared To bISoprolol on cenTral Pulse Pressure in Hypertension (ARTIST) Study Registry record

    Expected 2013-04; that period ended on 2013-04-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01243827

  5. Study completion Rosuvastatin Effect on Reducing Coronary Atherosclerosis Plaques Volume Registry record

    Expected 2013-04; that period ended on 2013-04-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01382277

  6. Primary completion Rosuvastatin Effect on Reducing Coronary Atherosclerosis Plaques Volume Registry record

    Expected 2013-04; that period ended on 2013-04-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01382277

  7. Study completion Randomized Trial of Standard vs ClearWay-infused Abciximab and Thrombectomy for Myocardial Infarction Registry record

    Expected 2013-04; that period ended on 2013-04-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01499407

  8. Primary completion Efficacy and Safety of Xience in Coronary arEry Disease aLL-comers After stENTing Using the PRIME Platform (EXCELLENT-PRIME Registry) Registry record

    Expected 2013-04; that period ended on 2013-04-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01605721

  9. Study completion Diagnostic Performance of Noninvasive Fractional Flow Reserve From Computed Tomography Registry record

    Expected 2013-04; that period ended on 2013-04-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01747317

  10. Primary completion Efficacy and Safety Study of Azimilide on the Incidence of Cardiovascular Hospitalizations/Emergency Department Visits or Cardiovascular Death in Patients With an Implantable Cardioverter Defibrillator (ICD) (SHIELD-2) Registry record

    Expected 2013-05; that period ended on 2013-05-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01464476

  11. Primary completion A Randomized Trial of Angiotensin Receptor bLocker,Fimasartan, in Aortic Stenosis (ALFA Trial) Registry record

    Expected 2013-05; that period ended on 2013-05-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01589380

  12. Study completion The Association Between Very Small Embryonic-like Stem Cells and the Prognosis of Coronary Artery Disease Patients Registry record

    Expected 2013-05; that period ended on 2013-05-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01633359

  13. Primary completion Physiologic Assessment of Thrombus Aspiration in Acute ST-segment Elevation Myocardial Infarction Patients Registry record

    Expected 2013-05; that period ended on 2013-05-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01824641

  14. Study completion A Registry To Evaluate Safety And Effectiveness Of Everolimus Drug Eluting Stent For Coronary Revascularization Registry record

    Expected 2013-06; that period ended on 2013-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01157455

  15. Study completion Evaluation of Efficacy and Safety of Dapagliflozin as Monotherapy in Subjects With Type 2 Diabetes Who Have Inadequate Glycaemic Control With Diet and Exercise Alone Registry record

    Expected 2013-06; that period ended on 2013-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01257412

  16. Primary completion Evaluation of Efficacy and Safety of Dapagliflozin as Monotherapy in Subjects With Type 2 Diabetes Who Have Inadequate Glycaemic Control With Diet and Exercise Alone Registry record

    Expected 2013-06; that period ended on 2013-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01257412

  17. Study completion Efficacy and Safety Study of Azimilide on the Incidence of Cardiovascular Hospitalizations/Emergency Department Visits or Cardiovascular Death in Patients With an Implantable Cardioverter Defibrillator (ICD) (SHIELD-2) Registry record

    Expected 2013-06; that period ended on 2013-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01464476

  18. Primary completion Oral Anticoagulation and Self-management Registry record

    Expected 2013-06; that period ended on 2013-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01878539

  19. Primary completion Significance of Regional Ventriculo-arterial Coupling in Patients With Chronic Heart Failure Registry record

    Expected 2013-07; that period ended on 2013-07-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01156207

  20. Primary completion Optimized Strategy for Diabetic Patients With Critical Limb Ischemia(Part II) (DCLI-II) Registry record

    Expected 2013-07; that period ended on 2013-07-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01173094

  21. Study completion Safety and Effectiveness of the Coronary Momo Stent Registry record

    Expected 2013-07; that period ended on 2013-07-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01535625

  22. Primary completion Efficacy and Safety Study of 5 mg and 10 mg Rosuvastatin Registry record

    Expected 2013-07; that period ended on 2013-07-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01613729

  23. Study completion COmparison of Xience PrimE Versus REsolute Integrity in Diabetes or Small Vessel Disease Registry record

    Expected 2013-07; that period ended on 2013-07-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01752127

  24. Primary completion COmparison of Xience PrimE Versus REsolute Integrity in Diabetes or Small Vessel Disease Registry record

    Expected 2013-07; that period ended on 2013-07-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01752127

  25. Primary completion Feasible Insulin Algorithm for Glycemic Control in Patients With Acute Coronary Syndrome Registry record

    Expected 2013-08; that period ended on 2013-08-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01151176

  26. Primary completion Prevention of Contrast Induced Nephropathy by Erythropoietin Registry record

    Expected 2013-08; that period ended on 2013-08-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01364402

  27. Primary completion Shensong Yangxin Capsule in the Treatment of Heart Failure Complicated With Ventricular Premature Beat Registry record

    Expected 2013-08; that period ended on 2013-08-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01612260

  28. Study completion Comparison of Antiplatelet Effect of Ticagrelor vs Tirofiban in Patients With Non-ST Elevation Acute Coronary Syndrome Registry record

    Expected 2013-08; that period ended on 2013-08-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01660373

  29. Primary completion Comparison of Antiplatelet Effect of Ticagrelor vs Tirofiban in Patients With Non-ST Elevation Acute Coronary Syndrome Registry record

    Expected 2013-08; that period ended on 2013-08-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01660373

  30. Study completion Efficacy of Amlodipine-folic Acid Tablets on Reduction of Blood Pressure and Plasma Homocysteine Registry record

    Expected 2013-08; that period ended on 2013-08-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01848873

  31. Primary completion Efficacy of Amlodipine-folic Acid Tablets on Reduction of Blood Pressure and Plasma Homocysteine Registry record

    Expected 2013-08; that period ended on 2013-08-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01848873

  32. Primary completion Bedside Sleep Medicine Registry record

    Expected 2013-08; that period ended on 2013-08-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01924507

  33. Primary completion Efficacy and Safety of Hepatitis B Vaccine in Chronic Kidney Disease Patients Registry record

    Expected 2013-08; that period ended on 2013-08-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01933412

  34. Study completion A Multicentre Trial on the Effectiveness of Physical Rehabilitation of Patients With Coronary Artery Disease: Aerobic Interval Training Versus Moderate Continuous Training. Registry record

    Expected 2013-09; that period ended on 2013-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01226225

  35. Primary completion A Multicentre Trial on the Effectiveness of Physical Rehabilitation of Patients With Coronary Artery Disease: Aerobic Interval Training Versus Moderate Continuous Training. Registry record

    Expected 2013-09; that period ended on 2013-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01226225

  36. Study completion Novel Treatment for Coronary Artery Disease Registry record

    Expected 2013-09; that period ended on 2013-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01228214

  37. Primary completion Trans-Radial Coronary Interventions Using A Sheathless Guiding Catheter Registry record

    Expected 2013-09; that period ended on 2013-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01327365

  38. Study completion Firebird 2 Versus Excel Sirolimus-eluting Stent in Treating Real-world Patients With Coronary Artery Disease Registry record

    Expected 2013-09; that period ended on 2013-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01373632

  39. Primary completion The Effect of Prophylactic Hemodialysis on the Morbidity and Mortality of the Patients With Chronic Kidney Disease Stages 3-4 Undergoing Coronary Artery Graft Bypass Registry record

    Expected 2013-09; that period ended on 2013-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01410617

  40. Primary completion Abrogation of Mitral Regurgitation Using the MitraClip System in High-Risk Patients Unsuitable for Surgery Registry record

    Expected 2013-09; that period ended on 2013-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01431222

  41. Primary completion ReStore Thrombectomy Trial for Flow Restoration in Acute Ischemic Stroke Patients Registry record

    Expected 2013-09; that period ended on 2013-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01437774

  42. Primary completion Association of Non-alcoholic Fatty Liver Disease and Coronary Artery Disease Registry record

    Expected 2013-09; that period ended on 2013-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01638832

  43. Primary completion Evaluate Safety And Effectiveness Of The Tivoli® DES and The Firebird2® DES For Treatment Coronary Revascularization Registry record

    Expected 2013-09; that period ended on 2013-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01681381

  44. Primary completion Shensongyangxin Capsule in the Treatment of Sinus Bradycardia With Premature Ventricular Contractions Registry record

    Expected 2013-09; that period ended on 2013-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01750775

  45. Primary completion The Effects of Coenzyme A Combined With Statin on Serum Lipids in Patients With Hyperlipidemia Registry record

    Expected 2013-09; that period ended on 2013-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01928342

  46. Primary completion Noninferiority Clinical Trial With Laryngeal Mask and Endotracheal Tube Registry record

    Expected 2013-10; that period ended on 2013-10-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01288248

  47. Primary completion Study Comparing Effects of Lanthanum Carbonate Versus Calcium Acetate Versus Dietary Phosphorus Restriction Registry record

    Expected 2013-10; that period ended on 2013-10-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01357317

  48. Primary completion Efficacy and Safety Study of Eprotirome in HeFH Patients Who Are on Optimal Standard of Care Registry record

    Expected 2013-10; that period ended on 2013-10-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01410383

  49. Study completion ReStore Thrombectomy Trial for Flow Restoration in Acute Ischemic Stroke Patients Registry record

    Expected 2013-10; that period ended on 2013-10-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01437774

  50. Study completion Value Antiproteinuric Effects From Vitamin D Derivatives in Patient With Chronic Kidney Illness and the Lack of Vitamin D Registry record

    Expected 2013-10; that period ended on 2013-10-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01442272

  51. Primary completion Creative Therapy to Affect Stroke Outcomes Registry record

    Expected 2013-10; that period ended on 2013-10-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01455155

  52. Primary completion Thyroxin Treatment in Sub Clinical Hypothyroidism, on the Apnea Hypopnea Index Score, Lipids and Highly Sensitive CRP Registry record

    Expected 2013-10; that period ended on 2013-10-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01486667

  53. Study completion Impact of Intravascular Ultrasound(IVUS)-Guided Chronic Total Occlusion Intervention With Drug-eluting Stents Registry record

    Expected 2013-10; that period ended on 2013-10-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01563952

  54. Primary completion Impact of Intravascular Ultrasound(IVUS)-Guided Chronic Total Occlusion Intervention With Drug-eluting Stents Registry record

    Expected 2013-10; that period ended on 2013-10-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01563952

  55. Study completion Renal Effects of an Angiotensin Converting Enzyme Inhibitor in Adults With Chronic Kidney Disease of Uncertain Aetiology Registry record

    Expected 2013-10; that period ended on 2013-10-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01624064

  56. Primary completion Early EEG-NF Intervention for the Prevention of PTSD Registry record

    Expected 2013-10; that period ended on 2013-10-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01729780

  57. Study completion Omeprazole and Pantoprazole Antiplatelet Effect of Clopidogrel Clinical Trials(OPEN) Registry record

    Expected 2013-10; that period ended on 2013-10-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01735227

  58. Primary completion Omeprazole and Pantoprazole Antiplatelet Effect of Clopidogrel Clinical Trials(OPEN) Registry record

    Expected 2013-10; that period ended on 2013-10-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01735227

  59. Primary completion Effects of Zolpidem CR® in Sleep and Heart Recovery in Cardiac Intensive Care Unit Patients Registry record

    Expected 2013-10; that period ended on 2013-10-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01920334

  60. Study completion The Effects of Coenzyme A Combined With Statin on Serum Lipids in Patients With Hyperlipidemia Registry record

    Expected 2013-10; that period ended on 2013-10-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01928342

  61. Primary completion A Phase Ⅲ Study of Extended-Release Carvedilol Sulfate for the Treatment of Hypertension Registry record

    Expected 2013-10; that period ended on 2013-10-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01970059

  62. Primary completion Two Weeks of Low Molecular Weight Heparin for Distal Vein Thrombosis Registry record

    Expected 2013-11; that period ended on 2013-11-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01252420

  63. Study completion Ranolazine, Ethnicity and the Metabolic Syndrome Registry record

    Expected 2013-11; that period ended on 2013-11-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01304095

  64. Primary completion Efficacy and Safety of Alprostadil Prevent Contrast Induced Nephropathy Registry record

    Expected 2013-11; that period ended on 2013-11-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01722513

  65. Study completion Physiologic Assessment of Thrombus Aspiration in Acute ST-segment Elevation Myocardial Infarction Patients Registry record

    Expected 2013-11; that period ended on 2013-11-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01824641

  66. Study completion Feasible Insulin Algorithm for Glycemic Control in Patients With Acute Coronary Syndrome Registry record

    Expected 2013-12; that period ended on 2013-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01151176

  67. Primary completion Latin America Cardiac Resynchronization Therapy Study Registry record

    Expected 2013-12; that period ended on 2013-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01238874

  68. Study completion Study of the Paclitaxel-Coated Balloon Catheter in Bifurcated Coronary Lesions Registry record

    Expected 2013-12; that period ended on 2013-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01278186

  69. Study completion Noninferiority Clinical Trial With Laryngeal Mask and Endotracheal Tube Registry record

    Expected 2013-12; that period ended on 2013-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01288248

  70. Study completion Prevention of Contrast Induced Nephropathy by Erythropoietin Registry record

    Expected 2013-12; that period ended on 2013-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01364402

  71. Primary completion Sodium Bicarbonate in Cardiopulmonary Resuscitation Registry record

    Expected 2013-12; that period ended on 2013-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01377337

  72. Study completion The Effect of Prophylactic Hemodialysis on the Morbidity and Mortality of the Patients With Chronic Kidney Disease Stages 3-4 Undergoing Coronary Artery Graft Bypass Registry record

    Expected 2013-12; that period ended on 2013-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01410617

  73. Primary completion Continuous Subcutaneous Insulin Infusion strAtegy Versus Multiple Daily Insulin Injections strAtegy Registry record

    Expected 2013-12; that period ended on 2013-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01574508

  74. Study completion Renal Toxicity of Iodixanol and Iopromide in Patients With Renal Dysfunction Registry record

    Expected 2013-12; that period ended on 2013-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01580046

  75. Primary completion Renal Toxicity of Iodixanol and Iopromide in Patients With Renal Dysfunction Registry record

    Expected 2013-12; that period ended on 2013-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01580046

  76. Primary completion The Effect Of Antiplatelets Therapy On Saphenous Vein Coronary Artery Bypass Graft Patency Registry record

    Expected 2013-12; that period ended on 2013-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01598337

  77. Study completion Shensong Yangxin Capsule in the Treatment of Heart Failure Complicated With Ventricular Premature Beat Registry record

    Expected 2013-12; that period ended on 2013-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01612260

  78. Study completion Efficacy and Safety Study of 5 mg and 10 mg Rosuvastatin Registry record

    Expected 2013-12; that period ended on 2013-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01613729

  79. Study completion Association of Non-alcoholic Fatty Liver Disease and Coronary Artery Disease Registry record

    Expected 2013-12; that period ended on 2013-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01638832

  80. Primary completion THalidomide on Left ventricUlar Morphology aND Function in congEstive heaRt Failure Registry record

    Expected 2013-12; that period ended on 2013-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01640639

  81. Primary completion Resistant Hypertension Optimal Treatment Registry record

    Expected 2013-12; that period ended on 2013-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01643434

  82. Primary completion Study Examining the PROMUS Element Everolimus-eluting Stent in Multi-center Coronary Intervention of Complex Arterial Lesion Subsets Registry record

    Expected 2013-12; that period ended on 2013-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01670318

  83. Primary completion Fenoldopam for Prevention of Acute Kidney Injury Registry record

    Expected 2013-12; that period ended on 2013-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01690832

  84. Primary completion ß-Cell Function and Glycemic Control in Newly Diagnosed Type 2 Diabetic Patients With Moderate Hyperglycemia Registry record

    Expected 2013-12; that period ended on 2013-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01717911

  85. Study completion Shensongyangxin Capsule in the Treatment of Sinus Bradycardia With Premature Ventricular Contractions Registry record

    Expected 2013-12; that period ended on 2013-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01750775

  86. Primary completion Efficacy of Acarbose on Intestinal Microbiome and Incretins of Type 2 Diabetes Registry record

    Expected 2013-12; that period ended on 2013-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01758471

  87. Primary completion Atorvastatin for Reduction of Myocardial Damage During Angiography and Its Mechanism Associated With IMR Registry record

    Expected 2013-12; that period ended on 2013-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01761656

  88. Primary completion Multivessel Stenting Versus Staged Revascularization With Zotarolimus-eluting Stent for STEMI Registry record

    Expected 2013-12; that period ended on 2013-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01781715

  89. Study completion Paricalcitol on Albuminuria, Inflammation and Fibrosis on Proteinuric Chronic Renal Diseases (PALIFE Study) Registry record

    Expected 2013-12; that period ended on 2013-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01820078

  90. Primary completion Efficacy of Amlodipine-Folic Acid Tablets on Reduction of Blood Pressure and Plasma Homocysteine Registry record

    Expected 2013-12; that period ended on 2013-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01956786

  91. Study completion Randomized Trial of Creatine-kinase Leak After Rosuvastatin At the Time of Percutaneous Coronary Intervention Registry record

    Expected 2013-12; that period ended on 2013-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01968577

  92. Primary completion Randomized Trial of Creatine-kinase Leak After Rosuvastatin At the Time of Percutaneous Coronary Intervention Registry record

    Expected 2013-12; that period ended on 2013-12-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01968577

  93. Primary completion The Effect of Moxonidine on Blood Pressure and Regression of Early Target Organ Damage in Young Subjects With Abdominal Obesity and Hypertension Registry record

    Expected 2014-01; that period ended on 2014-01-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01360710

  94. Study completion Assessment of Stent Malapposition and Neointimal Coverage on Optical coHerence Tomography at Post-procedure and 3 Months After Platinum Chromium Alloy Of the Element™ Stent Implantation Registry record

    Expected 2014-01; that period ended on 2014-01-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01581515

  95. Primary completion Assessment of Stent Malapposition and Neointimal Coverage on Optical coHerence Tomography at Post-procedure and 3 Months After Platinum Chromium Alloy Of the Element™ Stent Implantation Registry record

    Expected 2014-01; that period ended on 2014-01-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01581515

  96. Primary completion Cotavance™ Paclitaxel-Coated Balloon Versus Uncoated Balloon Angioplasty for Treatment of In-stent Restenosis in SFA and Popliteal Arteries Registry record

    Expected 2014-01; that period ended on 2014-01-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01594684

  97. Study completion Use of Standardized Diagnostic Imaging Data for Image Fusion in the Hybrid Operating Room Registry record

    Expected 2014-01; that period ended on 2014-01-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01821651

  98. Primary completion Use of Standardized Diagnostic Imaging Data for Image Fusion in the Hybrid Operating Room Registry record

    Expected 2014-01; that period ended on 2014-01-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01821651

  99. Study completion Effects of Zolpidem CR® in Sleep and Heart Recovery in Cardiac Intensive Care Unit Patients Registry record

    Expected 2014-01; that period ended on 2014-01-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01920334

  100. Primary completion Efficacy and Safety of SP2086 as Monotherapy in Patients With Type 2 Diabetes Registry record

    Expected 2014-01; that period ended on 2014-01-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01970033